[Comment] Clinical trial priorities, adaptive strategies, and equitable partnerships for the Bundibugyo Ebola outbreak | ClinicLens
The ongoing outbreak of Bundibugyo virus disease in the Democratic Republic of the Congo and Uganda exposes a recurrent weakness in filovirus preparedness: clinical research systems are still too often activated after, rather than before, epidemics accelerate.1,2 Unlike disease c
Medical Literature · Updated
← Back to articlesIf the embedded page does not load in your browser, open it directly.